» Articles » PMID: 36971568

A Single Intranasal Dose of Bacterial Therapeutics to Calves Confers Longitudinal Modulation of the Nasopharyngeal Microbiota: a Pilot Study

Overview
Journal mSystems
Specialty Microbiology
Date 2023 Mar 27
PMID 36971568
Authors
Affiliations
Soon will be listed here.
Abstract

To address the emergence of antimicrobial-resistant pathogens in livestock, microbiome-based strategies are increasingly being sought to reduce antimicrobial use. Here, we describe the effects of intranasal application of bacterial therapeutics (BTs) on the bovine respiratory microbiota and used structural equation modeling to investigate the causal networks after BT application. Beef cattle received (i) an intranasal cocktail of previously characterized BT strains, (ii) an injection of metaphylactic antimicrobial (tulathromycin), or (iii) intranasal saline. Despite being transient colonizers, inoculated BT strains induced longitudinal modulation of the nasopharyngeal bacterial microbiota while showing no adverse effect on animal health. The BT-mediated changes in bacteria included reduced diversity and richness and strengthened cooperative and competitive interactions. In contrast, tulathromycin increased bacterial diversity and antibiotic resistance and disrupted bacterial interactions. Overall, a single intranasal dose of BTs can modulate the bovine respiratory microbiota, highlighting that microbiome-based strategies have potential in being utilized to mitigate bovine respiratory disease in feedlot cattle. Bovine respiratory disease (BRD) remains the most significant health challenge affecting the North American beef cattle industry and results in $3 billion in economic losses yearly. Current BRD control strategies mainly rely on antibiotics, with metaphylaxis commonly employed to mitigate BRD incidence in commercial feedlots. However, the emergence of multidrug-resistant BRD pathogens threatens to reduce the efficacy of antimicrobials. Here, we investigated the potential use of novel bacterial therapeutics (BTs) to modulate the nasopharyngeal microbiota in beef calves, which are commonly administered metaphylactic antibiotics to mitigate BRD when sourced from auction markets. By direct comparison of the BTs with an antibiotic commonly used for BRD metaphylaxis in feedlots, this study conveyed the potential use of the BTs to modulate respiratory microbiome and thereby improve resistance against BRD in feedlot cattle.

Citing Articles

Stochasticity Highlights the Development of Both the Gastrointestinal and Upper-Respiratory-Tract Microbiomes of Neonatal Dairy Calves in Early Life.

Frazier A, Ferree L, Belk A, Al-Lakhen K, Cramer M, Metcalf J Animals (Basel). 2025; 15(3).

PMID: 39943131 PMC: 11816138. DOI: 10.3390/ani15030361.


Effects of vaccination and interventions on nasal microbiome and BRD-associated pathogens in calves.

Liu G, Zhang S, Xiang Z, Shirani I, Chen Y, Guo A Front Microbiol. 2024; 15:1467908.

PMID: 39624725 PMC: 11610248. DOI: 10.3389/fmicb.2024.1467908.


Effects of dietary restriction and one-carbon metabolite supplementation during the first 63 days of gestation on the maternal gut, vaginal, and blood microbiota in cattle.

Luecke S, Aryee G, Holman D, Schmidt K, King L, Crouse M Anim Microbiome. 2024; 6(1):48.

PMID: 39210404 PMC: 11360793. DOI: 10.1186/s42523-024-00335-2.


The respiratory and fecal microbiota of beef calves from birth to weaning.

Uddin M, Ortiz Guluarte J, Waldner M, Alexander T mSystems. 2024; 9(7):e0023824.

PMID: 38899874 PMC: 11264934. DOI: 10.1128/msystems.00238-24.


Screening and selection of essential oils for an intranasal spray against bovine respiratory pathogens based on antimicrobial, antiviral, immunomodulatory, and antibiofilm activities.

Amat S, Magossi G, Rakibuzzaman A, Holman D, Schmidt K, Kosel L Front Vet Sci. 2024; 11:1360398.

PMID: 38384959 PMC: 10879409. DOI: 10.3389/fvets.2024.1360398.